Resumo

GALLEGOS-VILLALOBOS, Ángel et al. Use of radioactive iodine I-131 and monitoring of radioactivity in patients with chronic kidney disease on haemodialysis. Nefrología (Madr.) [online]. 2014, vol.34, n.3, pp.317-322. ISSN 1989-2284.  https://dx.doi.org/10.3265/Nefrologia.pre2014.Jan.12442.

Thyroid carcinoma is a neoplasia with a higher incidence in patients with chronic kidney disease. In recent years advances have been made in diagnostic and therapeutic trials. Dialysis patients are a particular group, their cancer being detected indirectly in the study of secondary hyperparathyroidism and during the study prior to renal transplantation. Thyroidectomy is the definitive treatment, but in patients with risk of recurrence, ablative therapy is required using radioactive iodine I-131, which is predominantly eliminated by renal excretion, therefore its use in patients on dialysis poses a problem in terms of dosage. Two cases are presented of patients on haemodialysis undergoing radioablation with radioactive iodine I-131, which with multidisciplinary treatment had the expected results in the patients.

Palavras-chave : Haemodialysis; Radioactive iodine I-131.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )